NAPHCON A

This brand name is authorized in Canada, Ecuador, Hong Kong SAR China, New Zealand, Singapore.

Active ingredients

The drug NAPHCON A contains a combination of these active pharmaceutical ingredients (APIs):

1	Naphazoline UNII MZ1131787D - NAPHAZOLINE HYDROCHLORIDE
	Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity.
	Read more about Naphazoline
2	Pheniramine UNII NYW905655B - PHENIRAMINE MALEATE
	Read more about Pheniramine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GA51	Naphazoline, combinations	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00481408
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	25.699-06-04
HK	Department of Health Drug Office	17005
NZ	Medicines and Medical Devices Safety Authority	2429
SG	Health Sciences Authority	04717P